ECILC.IS
ECILC.IS
TRAECILC91E0
ECZACIBASI ILAC
Loading chart...

Company Profile

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.

Related stocks

2070.SR
2070.SR • Saudi Arabia
Saudi Pharmaceutical Industries
30.46 SAR
968.19M USD 1Y +2.8%
2230.SR
2230.SR • Saudi Arabia
Saudi Chemical Co.
7.22 SAR
1.62B USD 1Y +0.6%
4016.SR
4016.SR • Saudi Arabia
Middle East Pharmaceutical Indu
63.25 SAR
589.55M USD 1Y -17.4%
4015.SR
4015.SR • Saudi Arabia
Jamjoom Pharmaceuticals Factory
128 SAR
2.39B USD 1Y -19.2%
APN.JO
APN.JO • South Africa
Aspen Pharmacare Hldgs Ltd
15,826 ZAc
4.15B USD 1Y +65.2%
MEGA-R.BK
MEGA-R.BK • Thailand
MEGA_MEGA LIFESCIENCES
33.75 THB
878.9M USD 1Y +10.8%
AARTIPHARM.NS
AARTIPHARM.NS • India
AARTI PHARMALABS LIMITED
855.5 INR
801.58M USD 1Y +2.5%
002793.SZ
002793.SZ • China
LUOXINPHARMACEUTICAL
4.89 CNY
795.8M USD 1Y -0.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
50.7% p.a.
Max Drawdown (5Y)
-56.3%
Sharpe Ratio (5Y)
1.15
Beta Factor
0.28
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.3% in the extended horizon.
ende